Skip to main content
Victoria Bird, MD, Urology, Gainesville, FL, HCA Florida North Florida Hospital

VictoriaBirdMD

Urology Gainesville, FL

Surgical Oncology

CEO UIC National Medical Association and Research Group, Director

Dr. Bird is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bird's full profile

Already have an account?

Summary

  • Dr. Victoria Bird specializes in AI technology for diagnosis, treatment and management of prostate cancer, including AI Protégé MIMS/MRI US Fusion guided prostate biopsy using BK3000 US hardware for ablative technology as well as MRI guided ablative technology including TULSA PRO, this allows excellent detection cancer rates, which translates into accurate ablative technology applications.

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Urology, 2000 - 2005
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2007 - 2025
  • American Board of Urology Urology
  • National Institutes of Heath, Office of Extramural ResearchProtecting Human Research Participants

Awards, Honors, & Recognition

  • UF Patient Key Award UF, 2017
  • Patient Key Awards UF, 2016

Publications & Presentations

PubMed

Journal Articles

  • Development of a personalized diagnostic model for kidney stone disease tailored to acute care by integrating large clinical, demographics and laboratory data: the dia...  
    Zhaoyi Chen, Victoria Bird, Mattia Prosperi, BMC Medical Informatics and Decision Making201818:72 https://doi.org/10.1186/s12911-018-0652-4© The Author(s). 2018 Received: 31 October 2017Accepted: 6 August 2018Published: 17 August 2018, 8/17/2018
  • A new approach to disentangle genetic and epigenetic components on disease comorbidities: studying correlation between genotypic and phenotypic disease networks.  
    Tradigo G, Vacca R, Manini T, Bird V, Gerke T, Veltri P, Prosperi M., Procedia Computer Science 2017; 110:453–458. https://doi.org/10.1016/j.procs.2017.06.119., 6/11/2017
  • Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review  
    Zhaoyi Chen a Travis Gerke b Victoria Bird c Mattia Prosperi a, Biomed Hub 2017;2:472146 (DOI: 10.1159/000472146), 5/17/2017

Authored Content

  • Personalized Diagnostic Model For Severe Kidney Stone Disease8/17/2018

Other Languages

  • Spanish

Hospital Affiliations